MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Peregrine Pharmaceuticals Company Profile (NASDAQ:PPHM)

Consensus Ratings for Peregrine Pharmaceuticals (NASDAQ:PPHM) (?)
Ratings Breakdown: 1 Hold Rating(s), 2 Buy Rating(s)
Consensus Rating:Buy (Score: 2.67)
Consensus Price Target: $2.17 (495.07% upside)

Analysts' Ratings History for Peregrine Pharmaceuticals (NASDAQ:PPHM)
Show:
DateFirmActionRatingPrice TargetActions
6/4/2016FBR & Co.Reiterated RatingBuy$1.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/26/2016Roth CapitalDowngradeBuy -> Neutral$3.00 -> $0.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/14/2015Noble FinancialReiterated RatingBuy$5.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/1/2015MLV & Co.Reiterated RatingBuy$3.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/30/2014 forward)
Earnings History for Peregrine Pharmaceuticals (NASDAQ:PPHM)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
7/12/2016        
3/9/2016Q316($0.07)($0.08)$7.96 million$6.71 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
12/10/2015Q216($0.09)($0.07)$9.52 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
9/9/2015Q116($0.08)($0.08)$9.67 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/14/2015Q315($0.08)($0.07)$6.42 million$9.31 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/12/2015Q215($0.08)($0.08)$4.20 million$5.68 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
12/10/2014Q115($0.07)($0.07)$5.82 million$6.30 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
9/9/2014Q1($0.06)($0.08)$5.76 million$5.50 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/14/2014Q414($0.07)($0.06)$4.75 million$6.47 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/7/2014Q314($0.06)($0.06)$5.09 million$3.90 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
12/10/2013Q2($0.05)($0.05)$5.74 million$7.35 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
9/9/2013Q1 2014($0.05)($0.05)$4.75 million$4.69 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/11/2013Q4 2013($0.06)($0.06)$3.57 million$4.25 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/12/2013Q3 2013($0.07)($0.04)$3.90 million$7.04 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
12/10/2012-0.08($0.09)($0.08)$4.03 million$4.03 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
9/10/2012Q113($0.11)($0.07)$3.97 million$4.25 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/16/2012($0.13)($0.10)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/9/2012($0.13)($0.13)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
12/12/2011($0.13)($0.16)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
9/9/2011($0.14)($0.11)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for Peregrine Pharmaceuticals (NASDAQ:PPHM)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q3 20161($0.05)($0.05)($0.05)
Q4 20161($0.05)($0.05)($0.05)
Q1 20171($0.05)($0.05)($0.05)
Q2 20171($0.04)($0.04)($0.04)
(Data provided by Zacks Investment Research)
Dividend History for Peregrine Pharmaceuticals (NASDAQ:PPHM)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for Peregrine Pharmaceuticals (NASDAQ:PPHM)
No insider trades for this company have been tracked by MarketBeat.com

Latest Headlines for Peregrine Pharmaceuticals (NASDAQ:PPHM)
DateHeadline
06/28/16 05:50 PMPeregrine Pharmaceuticals Inc. (NASDAQ:PPHM) Company Rating and Target Watch - Telanagana Press
06/27/16 05:54 PMNotable Stock's Buzzers: Whiting Petroleum Corp (NYSE:WLL), Peregrine Pharmaceuticals (NASDAQ:PPHM) - NYSE Journal (press release)
06/27/16 05:54 PMStrong Sell Calls Recommendations For Peregrine Pharmaceuticals Inc. (NASDAQ:PPHM) At 0 - Investor Newswire
06/27/16 10:03 AMShare Update and Earnings Review for Peregrine Pharmaceuticals Inc. (NASDAQ:PPHM) - Press Telegraph
06/27/16 10:03 AMQUALCOMM, Inc. (NASDAQ:QCOM) & Peregrine Pharmaceuticals (NASDAQ:PPHM) News Recap - Wall Street 24
06/27/16 10:03 AMHC Stocks News: Peregrine Pharmaceuticals (NASDAQ:PPHM), Boston Scientific Corporation (NYSE:BSX) - share market updates (press release)
06/25/16 05:20 PMCovering the Bases on Peregrine Pharmaceuticals Inc. (NASDAQ:PPHM): Where is the Stock Going? - Press Telegraph
06/25/16 05:20 PMPeregrine Pharmaceuticals Inc. (PPHM) Current Analyst Ratings - Fiscal Standard
06/25/16 05:20 PMPrice Target Update on Peregrine Pharmaceuticals (NASDAQ:PPHM) - Trade Calls
06/20/16 05:41 PMStrong Buy Calls Count For Peregrine Pharmaceuticals Inc. (NASDAQ:PPHM) At 2 - Investor Newswire
06/20/16 07:29 AMThis Weeks Broker Views For Peregrine Pharmaceuticals Inc. (PPHM) - Fiscal Standard
06/15/16 10:30 AMMost Active Stocks Update: WestRock Company (NYSE:WRK), Peregrine Pharmaceuticals (NASDAQ:PPHM) - Beacon Chronicle
06/15/16 10:30 AMHC Stocks Growth: Peregrine Pharmaceuticals (NASDAQ:PPHM), Zimmer Biomet Holdings Inc (NYSE:ZBH) - share market updates (press release)
06/15/16 10:30 AMFloating Price Update: Peregrine Pharmaceuticals Inc. (NASDAQ:PPHM) , PharmAthene, Inc (NYSEMKT:PIP) - Street Updates
06/11/16 08:46 AMEarnings Overview: Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM), Xenoport, Inc. (NASDAQ:XNPT) - Beacon Chronicle
06/11/16 08:46 AMPeregrine Pharmaceuticals Inc. (PPHM) Drops 7.39% on June 09 - Equities.com
06/10/16 08:56 AMMost Recent Update on Price Moves: Catalent, Inc. (NYSE:CTLT) , Peregrine Pharmaceuticals Inc. (NASDAQ:PPHM) - Street Updates
06/06/16 05:51 PMPeregrine's Phase III Failure Creates Opportunity Revisit - Seeking Alpha
06/06/16 09:36 AMHC Stocks Zone: Pernix Therapeutics Holdings Inc (NASDAQ:PTX), Peregrine Pharmaceuticals (NASDAQ:PPHM) - share market updates (press release)
06/06/16 09:36 AMPeregrine Pharmaceuticals (NASDAQ:PPHM) Restructures Its Leadership - Journal Transcript
06/06/16 09:36 AMRevenue Estimates to Track: Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) - News Oracle
06/06/16 09:36 AMPeregrine Pharmaceuticals (PPHM) Receives Buy Rating from FBR & Co. - Let Me Know About This
06/04/16 05:58 PMNews Fact on Vanguard Level- Peregrine Pharmaceuticals (NASDAQ:PPHM), Easterly Government Properties (NYSE ... - Seneca Globe
06/03/16 06:28 PMHealthcare Concerns Warier in Focus- Peregrine Pharmaceuticals (NASDAQ:PPHM), Celator Pharmaceuticals ... - Seneca Globe
06/03/16 06:28 PMTwo Buzzers within Analysts Radar: Peregrine Pharmaceuticals Inc. (NASDAQ:PPHM) , Celldex Therapeutics, Inc ... - Street Updates
06/03/16 03:39 PMPEREGRINE PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers -
06/03/16 08:48 AMNovavax, Inc. (NASDAQ:NVAX) & Peregrine Pharmaceuticals (NASDAQ:PPHM) Eye-Catching Healthcare Stocks - Wall Street 24 - Novavax, Inc. (NASDAQ:NVAX) & Peregrine Pharmaceuticals (NASDAQ:PPHM) Eye-Catching Healthcare StocksWall Street 24On Thursday, Shares of Novavax, Inc. (NASDAQ:NVAX) gained 2.61% to $6.30. The share price is trading in a range of $6.10 – $6.30. The stock exchanged hands with 5.04 Million shares contrast to its average daily volume of 5.20 Million shares. Navient ...and more »
06/03/16 08:48 AMPeregrine Pharmaceuticals (NASDAQ:PPHM) & Cellectar Biosciences (NASDAQ:CLRB) Healthcare News Buzz - Wall Street 24 - Peregrine Pharmaceuticals (NASDAQ:PPHM) & Cellectar Biosciences (NASDAQ:CLRB) Healthcare News BuzzWall Street 24On Thursday, Shares of Peregrine Pharmaceuticals (NASDAQ:PPHM) gained 16.33% to $0.500. The share price is trading in a range of $0.49 – $0.67. The stock exchanged hands with 16.39 Million shares contrast to its average daily volume of 1.02 Million ...and more »
06/03/16 08:48 AMHC Stocks Updates: Pernix Therapeutics Holdings Inc (NASDAQ:PTX), Peregrine Pharmaceuticals (NASDAQ:PPHM) - share market updates (press release) - share market updates (press release)HC Stocks Updates: Pernix Therapeutics Holdings Inc (NASDAQ:PTX), Peregrine Pharmaceuticals (NASDAQ:PPHM)share market updates (press release)Shares of Pernix Therapeutics Holdings Inc (NASDAQ:PTX) ended Thursday session in red amid volatile trading. The shares closed down -0.006 points or -1.29% at $0.460 with 3.91 million shares getting traded. Post opening the session at $0.47, the shares ...and more »
06/03/16 08:48 AMTrader's Healthcare Focused Stocks: Peregrine Pharmaceuticals Inc. (NASDAQ:PPHM) , Dermira, Inc. (NASDAQ:DERM) - Is stories - Trader's Healthcare Focused Stocks: Peregrine Pharmaceuticals Inc. (NASDAQ:PPHM) , Dermira, Inc. (NASDAQ:DERM)Is storiesPeregrine Pharmaceuticals Inc. (NASDAQ:PPHM) initiated the shares trading at $0.5130 and showed positive change of +16.3294% while the stock's final trade was registered at $ 0.5001. However, its previous closing price was seen at $0.4299. The stock ...Stocks to Watch: Peregrine Pharmaceuticals (NASDAQ:PPHM), Shire PLC (ADR)(NASDAQ:SHPG)NYSE Journal (press release)Active Stocks Need to Consider: Peregrine Pharmaceuticals (NASDAQ:PPHM), Exelon (NYSE:EXC), Kite Pharma ...Seneca GlobeTwo Biotechnology Names Are Hot: Merrimack Pharmaceuticals, Inc. (MACK), Peregrine Pharmaceuticals, Inc. (PPHM)Zergwatchall 9 news articles »
06/02/16 06:20 PMPeregrine Pharmaceuticals Inc. (NASDAQ:PPHM) Stock Update & Estimates - Stock Tick Tock - Peregrine Pharmaceuticals Inc. (NASDAQ:PPHM) Stock Update & EstimatesStock Tick TockThe consensus on Wall Street is expecting Peregrine Pharmaceuticals Inc. (NASDAQ:PPHM) to post earnings of $-0.04 per share when the firm next reports it's fiscal quarterly results. According to the latest information available the report will likely ...and more »
06/02/16 06:19 PMPeregrine Pharmaceuticals Inc. (PPHM) Jumps 16.33% on June 02 - Equities.com - Peregrine Pharmaceuticals Inc. (PPHM) Jumps 16.33% on June 02Equities.comPeregrine Pharmaceuticals Inc. (PPHM) was among the biggest gainers on the Russell 2000 for Thursday June 02 as the stock popped 16.33% to $0.50, representing a gain of $0.0702 per share. Some 15.39 million shares traded hands on 14,276 trades, ...and more »
06/02/16 06:19 PMPeregrine Pharmaceuticals Inc (NASDAQ:PPHM) Explodes Higher - Insider Financial - Insider FinancialPeregrine Pharmaceuticals Inc (NASDAQ:PPHM) Explodes HigherInsider FinancialWe at Insider Financial have been pounding the table all year on Peregrine Pharmaceuticals Inc (NASDAQ:PPHM). We've been saying that the company remained undervalued and that better days were ahead for the company and its shareholders. The latest ...Peregrine Pharmaceuticals Stock Faces Higher Risks Forward After Forming Bearish Double Bottom Chart PatternFranklin IndependentWorthy Stocks in the Spotlight: Eleven Biotherapeutics Inc (NASDAQ:EBIO), Peregrine Pharmaceuticals (NASDAQ ...The Point ReviewPeregrine Gains More Than 20% Pre-Bell on Subsidiary Outlook (NASDAQ:PPHM)Sonoran Weekly ReviewFierceBiotechall 5 news articles »
06/02/16 01:42 PMThursday Sector Leaders: Biotechnology, Drugs - In trading on Thursday, biotechnology shares were relative leaders, up on the day by about 1.5%. Leading the group were shares of Peregrine Pharmaceuticals (PPHM), up about 32.6% and shares of Keryx Biopharmaceuticals (KERX) up about 15% on the day.
06/02/16 08:54 AMTarget Price and Stock Performance Rundown for Peregrine Pharmaceuticals Inc. (NASDAQ:PPHM) - HNN - Target Price and Stock Performance Rundown for Peregrine Pharmaceuticals Inc. (NASDAQ:PPHM)HNNDuring the latest trading session, Peregrine Pharmaceuticals Inc. (NASDAQ:PPHM) shares traded +1.9203%. Monitoring the stock price relative to moving averages may offer enhanced perspective on stock performance. After a recent check, shares have ...and more »
06/02/16 08:54 AMHealthcare Stocks in the Spotlight: Peregrine Pharmaceuticals (NASDAQ:PPHM), Portola Pharmaceuticals Inc ... - NYSE Journal (press release) - Share Trading NewsHealthcare Stocks in the Spotlight: Peregrine Pharmaceuticals (NASDAQ:PPHM), Portola Pharmaceuticals Inc ...NYSE Journal (press release)On Tuesday, Shares of Peregrine Pharmaceuticals (NASDAQ:PPHM), added 1.79% and closed at $0.422 in the last trading session. The last trading range of the stock ranges between $0.41 and $0.44. Avid Bioservices, Inc., a wholly owned partner of ...Two Biotech Stocks Are Just So Hot Right Now: Agenus (AGEN), Peregrine Pharmaceuticals (PPHM)Zergwatchall 20 news articles »
06/02/16 08:54 AMTrading Overview of Two Stocks: Peregrine Pharmaceuticals Inc. (NASDAQ:PPHM) , Corbus Pharmaceuticals Holdings ... - Street Updates - Trading Overview of Two Stocks: Peregrine Pharmaceuticals Inc. (NASDAQ:PPHM) , Corbus Pharmaceuticals Holdings ...Street UpdatesIn the liquidity ratio analysis; Peregrine Pharmaceuticals, Inc.'s (PPHM) debt to equity ratio was 0.00 while current ratio was 1.60. The company has the institutional ownership of 17.00% while the Beta factor was 1.30. The stock's RSI amounts to 67.27.and more »
06/02/16 07:25 AMPeregrine Pharmaceuticals Provides Corporate Update Highlighting Latest Developments for Contract Manufacturing and Drug Development Businesses - [at noodls] - June 2, 2016 - Contract Manufacturing Revenue Hits All-Time High of $44 Million for Fiscal Year Ended April 2016; Fiscal Year 2017 Contract Manufacturing Revenue Projected Between $50-55 Million; Continued ...
06/02/16 07:08 AM8:08 am Peregrine Pharma highlights latest developments for contract manufacturing and drug development; FY17 contract manufacturing revenue projected between $50-55 mln -
06/01/16 08:49 AMNew Broker Ratings For Peregrine Pharmaceuticals Inc. (PPHM) - FTSE News - Share Trading NewsNew Broker Ratings For Peregrine Pharmaceuticals Inc. (PPHM)FTSE News01/17/2014 – Peregrine Pharmaceuticals Inc. had its “” rating reiterated by analysts at JP Morgan. They now have a USD 9.5 price target on the stock. The share price of Peregrine Pharmaceuticals Inc. (PPHM) was up +1.79% during the last trading session ...Healthcare Stocks in the Spotlight: Peregrine Pharmaceuticals (NASDAQ:PPHM), Portola Pharmaceuticals Inc ...NYSE Journal (press release)New Analyst Ratings On Peregrine Pharmaceuticals Inc. (PPHM)Risers & FallersTwo Biotech Stocks Are Just So Hot Right Now: Agenus (AGEN), Peregrine Pharmaceuticals (PPHM)Zergwatchall 19 news articles »
05/30/16 05:20 PMStrong Sell Calls Count For Peregrine Pharmaceuticals Inc. (NASDAQ:PPHM) At 0 - Investor Newswire - Strong Sell Calls Count For Peregrine Pharmaceuticals Inc. (NASDAQ:PPHM) At 0Investor NewswirePeregrine Pharmaceuticals Inc. (NASDAQ:PPHM) has a total of 2 Strong Buy calls and 0 Strong Sell advises as of 2016-05-29. Zacks uses a rating procedure which assigns scores to stocks on a narrow 1-5 scale. When a stock gets a score of 1 or 2, it is ...and more »
05/30/16 05:20 PMStrong Sell Calls Count For Peregrine Pharmaceuticals Inc. (NASDAQ:PPHM) At 0 - Investor Newswire - Strong Sell Calls Count For Peregrine Pharmaceuticals Inc. (NASDAQ:PPHM) At 0Investor NewswirePeregrine Pharmaceuticals Inc. (NASDAQ:PPHM) has a total of 2 Strong Buy calls and 0 Strong Sell advises as of 2016-05-29. Zacks uses a rating procedure which assigns scores to stocks on a narrow 1-5 scale. When a stock gets a score of 1 or 2, it is ...and more »
05/30/16 05:20 PMPeregrine Pharmaceuticals Inc. (NASDAQ:PPHM) 1-Year High At $1.5000 - Investor Newswire - Peregrine Pharmaceuticals Inc. (NASDAQ:PPHM) 1-Year High At $1.5000Investor NewswireYesterday, the stock of Peregrine Pharmaceuticals Inc. (NASDAQ:PPHM) closed at $0.4100 after opening at $0.4100 and registering high of $0.4195 and low of $0.4093. The last price is $-1.0856 away 1-year high of $1.5000 and $0.1244 away from low of ...Peregrine Pharmaceuticals Incorporated (NASDAQ:PPHM) Shorted Shares Increased By 5.38%Franklin IndependentNext Weeks Broker Price Targets For Peregrine Pharmaceuticals Inc. (PPHM)Share Trading Newsall 3 news articles »
05/30/16 05:20 PMPeregrine Pharmaceuticals Inc. (NASDAQ:PPHM) 1-Year High At $1.5000 - Investor Newswire - Peregrine Pharmaceuticals Inc. (NASDAQ:PPHM) 1-Year High At $1.5000Investor NewswireYesterday, the stock of Peregrine Pharmaceuticals Inc. (NASDAQ:PPHM) closed at $0.4100 after opening at $0.4100 and registering high of $0.4195 and low of $0.4093. The last price is $-1.0856 away 1-year high of $1.5000 and $0.1244 away from low of ...Peregrine Pharmaceuticals Incorporated (NASDAQ:PPHM) Shorted Shares Increased By 5.38%Franklin IndependentNext Weeks Broker Price Targets For Peregrine Pharmaceuticals Inc. (PPHM)Share Trading Newsall 3 news articles »
05/26/16 10:31 PMStock Rating Review for Peregrine Pharmaceuticals Inc. (NASDAQ:PPHM) - Wall Street Hints and News - Stock Rating Review for Peregrine Pharmaceuticals Inc. (NASDAQ:PPHM)Wall Street Hints and NewsCovering equity analysts presently have a consensus stock rating of 1.67 on shares of Peregrine Pharmaceuticals Inc. (NASDAQ:PPHM). Covering analysts will often provide Sell, Hold, or Buy recommendations based on their advanced research.Peregrine Pharmaceuticals Inc. (NASDAQ:PPHM) Tracking Stock Rating and Target ProjectionsThe Postall 240 news articles »
05/26/16 10:31 PMPeregrine Pharmaceuticals Inc. (PPHM) Jumps 5.41% on May 25 - Equities.com - Peregrine Pharmaceuticals Inc. (PPHM) Jumps 5.41% on May 25Equities.comPeregrine Pharmaceuticals Inc. (PPHM) was among the biggest gainers on the Russell 2000 for Wednesday May 25 as the stock popped 5.41% to $0.42, representing a gain of $0.0218 per share. Some 979,977 shares traded hands on 1,327 trades, ...and more »
05/25/16 08:31 AMNoteworthy Movers of Last Trading Session: Peregrine Pharmaceuticals Inc. (NASDAQ:PPHM) , Illumina, Inc ... - Street Updates - Noteworthy Movers of Last Trading Session: Peregrine Pharmaceuticals Inc. (NASDAQ:PPHM) , Illumina, Inc ...Street UpdatesPeregrine Pharmaceuticals Inc. (NASDAQ:PPHM) accumulated +2.2059%, closing at $0.4031 after floating between $0.3801 and $0.4150. The company has market capitalization of $94.22M. It has twelve month low of $0.2900 and twelve month high of ...and more »
05/23/16 10:10 AMNotable movements of Stocks: Peregrine Pharmaceuticals Inc. (NASDAQ:PPHM) , Seattle Genetics, Inc. (NASDAQ ... - Street Updates - Notable movements of Stocks: Peregrine Pharmaceuticals Inc. (NASDAQ:PPHM) , Seattle Genetics, Inc. (NASDAQ ...Street UpdatesOn 5/20/2016, Peregrine Pharmaceuticals Inc. (NASDAQ:PPHM) ended trading session higher at $0.3901 with +2.6579%. The company traded a volume of 1.27 million shares as comparison to average volume of 1.74 million shares. During the 52 –week ...
05/23/16 10:10 AMHC Stock's Move to Focus: Peregrine Pharmaceuticals (NASDAQ:PPHM), Idera Pharmaceuticals Inc (NASDAQ:IDRA) - share market updates (press release) - share market updates (press release)HC Stock's Move to Focus: Peregrine Pharmaceuticals (NASDAQ:PPHM), Idera Pharmaceuticals Inc (NASDAQ:IDRA)share market updates (press release)Shares of Peregrine Pharmaceuticals (NASDAQ:PPHM) ended Friday session in green amid volatile trading. The shares closed up +0.010 points or 2.66% at $0.390 with 1.27 million shares getting traded. Post opening the session at $0.39, the shares hit an ...and more »
04/12/16 03:32 PMPEREGRINE PHARMACEUTICALS INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule -
About Peregrine Pharmaceuticals

Peregrine Pharmaceuticals logoPeregrine Pharmaceuticals, Inc. is a biopharmaceutical company with a portfolio of monoclonal antibodies in clinical trials for the treatment and diagnosis of cancer. The Company has two platforms and is pursuing multiple clinical programs in cancer with its lead immunotherapy candidate bavituximab, its phosphatidylserine (PS) targeting agent, PGN65, and its brain cancer therapy Cotara. Bavituximab is the Company's therapeutic PS-targeting antibody. PGN650 is its PS-targeting imaging agent. The Company is evaluating the bavituximab investigator-sponsored trials (IST) in front-line, HER2-negative metastatic breast cancer, liver cancer, rectal adenocarcinoma and advanced melanoma. It is also evaluating PGN650 imaging in multiple solid tumor types. The Company`s Impavido biomanufacturing subsidiary Avid Bioservices, Inc., provides commercial and clinical manufacturing services for the Company and third-party clients.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: PPHM
  • CUSIP:
Key Metrics:
  • Previous Close: $0.36
  • 50 Day Moving Average: $0.4157
  • 200 Day Moving Average: $0.6380
  • P/E Ratio: N/A
  • P/E Growth: 0.0000
  • Market Cap: $85.10M
  • Current Quarter EPS Consensus Estimate: $-0.2500 EPS
Additional Links:
Peregrine Pharmaceuticals (NASDAQ:PPHM) Chart for Thursday, June, 30, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha